AKT1 and cancer: In nonsmall‐cell lung cancer, miR‐99a‐5p was reported to suppress cancer cell proliferation and metastasis by controlling the AKT1 signaling pathway and insulin‐like growth factor‐1 receptor, which could also serve as a diagnostic biomarker 23, 44.